{
  "id": 15975998,
  "title": "UnitedHealth's Earnings Jumped 60%. Is the Comeback Stock a Buy, Sell, or Hold?",
  "url": "https://urgent.news/2026/10/22/unitedhealths-earnings-jumped-60-is-the-comeback-stock-a-buy-sell-or",
  "topic": "ai",
  "section": "AI",
  "published": "2026-10-22T00:00:00.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/10/21/unitedhealths-earnings-jumped-60-is-the-comeback-s/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "UnitedHealth Group (UNH) experienced a significant jump in earnings, with a 61% increase in adjusted earnings per share for the third quarter of 2026 compared to the same period last year. This strong performance exceeded Wall Street expectations, suggesting that the company's turnaround efforts are paying off. Revenue also outperformed forecasts, and management has raised its full-year adjusted earnings guidance to at least $20.50 per share, an improvement from the previous forecast of $19.50 to $20.00.\n\nWhat sets UnitedHealth apart is its focus on profitability rather than just revenue growth. By carefully pricing insurance plans, controlling medical expenses, and streamlining operations, the company is generating more profit from its existing business. This strategy is particularly encouraging given the rising cost of providing healthcare to its members. UnitedHealth's medical care ratio fell from 89.9% to 88.4%, indicating that the company is spending a smaller portion of its premiums on medical care and leaving more room for profit.\n\nThe improvement in UnitedHealth's medical care ratio is attributed to disciplined pricing, changes to insurance benefits, and enhanced medical cost management. Additionally, the company's Optum division, which provides healthcare services and pharmacy benefits, has shown significant improvement in operating earnings, reaching $735 million in the latest quarter compared to $41 million in the same period last year.\n\nWith both its core insurance business and Optum division showing promising results, investors are optimistic about UnitedHealth's stock. Wall Street analysts are bullish, with a Strong Buy consensus rating from 26 analysts and target prices ranging from $380 to $529 per share, implying up to 32% upside from the current price. However, UnitedHealth still faces challenges, including membership declines as the company reduces exposure to certain insurance plans and less profitable markets, as well as potential pressure from medical costs and stricter regulations.\n\nDespite these risks, the company's efforts to improve margins are showing positive results. If UnitedHealth can sustain its earnings recovery, the stock has the potential to deliver significant upside. Patient investors may consider holding or adding to their positions in UnitedHealth, anticipating further growth if the company continues to improve its profitability.",
  "summary": "UnitedHealth's third-quarter results beat estimates and lifted its outlook. Can tighter cost control and an Optum rebound keep the recovery going?",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}